Navigation Links
Alchem International Commits to Tropane Alkaloid APIs and Extends Production and Regulatory Support to Resolve Supply Gap
Date:9/15/2014

GENEVA, September 15, 2014 /PRNewswire/ --

Following the decision by the principal European manufacturers to exit or end market development and regulatory support for the niche range of Tropane Alkaloid APIs (active pharmaceutical ingredients) - including Atropine, Atropine Sulfate, Tropine, Nortropine, Homatropine Methylbromide, Homatropine Hydrobromide, Digoxin and Cimetropium Bromide - Alchem International (http://www.alcheminternational.com) has confirmed commitment to maintain production and regulatory (Drug Master File) support from its GMP production units.

     (Logo: http://photos.prnewswire.com/prnh/20140911/705609)

Raman Mehta, CEO and President at Alchem International, commented, "Whilst the tropane alkaloid family of APIs is a specialist business and difficult to manage within larger scale production facilities, Alchem International has invested in a suite of bespoke manufacturing and regulatory capabilities to support smaller scale, as well as, large scale API production and dossier support. 

Mr Mehta continued, "At short notice, Alchem International's R&D and regulatory teams have worked against the clock to provide a solution to our partner customers to resolve the supply gap and consequentially a potential withdrawal of these medicines from the market. This has been a significant undertaking and one we are proud to make, because we understand that, for customers, consistent supply of all APIs is vital, not only the mainstream ones."

Alchem International will be participating at CPHI Worldwide 2014 in Paris, the world's leading pharmaceutical networking event, from the 6th of October 2014 to the 9th October, at stand 6T55 

About Alchem International

Alchem International is a family-owned company, founded in 1935. A pioneer in phytochemicals, it has nearly 80 years' experience in supplying plant-derived active ingredients to the pharmaceutical, nutraceutical and cosmetics industries worldwide. Alchem International employs 1,100 people across its four international divisions in India, Europe, the United States and Hong Kong. Alchem operates WHO and FDA GMP approved manufacturing sites in India, which export 90% of their production volumes. The company has 18 DMF dossiers with filings in over 20 countries worldwide.  In addition to tropane alkaloids key products include Calcium sennosides, Colchicine, Enoxolone, Hysocine-N-Butylbromide, Nicotine, Thiocolchicoside and Vinpocetine.

 

Media contact
Robin Ward
Position. Business Development Director - Alchem International SA (Europe).
rward@alcheminternational.com
Tel. +41-91-604-6921
Mobile. +41-79-682-6621


'/>"/>
SOURCE Alchem International
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Alchem International sengage à poursuivre et étendre la production des principes pharmaceutiques actifs contenant des alcaloïdes tropaniques et à soutenir la réglementation pour combler lécart dapprovisionnement
2. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
3. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
4. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
5. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
6. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
7. Chindex International, Inc. to Report First Quarter 2012 Financial Results
8. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
9. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
10. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
11. Bacterin International Signs Its Third National GPO Contract with Novation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2019)... ... 2019 , ... Lake Minnetonka Orthodontics, with locations in Minnetonka, ... Hybrid-Responsive™ website: https://www.lakeminnetonkaortho.com . , The staff of Lake Minnetonka Orthodontics ... with the practice more easily online. Improvements include increased usability, online scheduling, and ...
(Date:9/18/2019)... , ... September 18, 2019 , ... The interns of ... all attended the Youth Consultation Services Foundation (YCS) in Hackensack , where NJ ... spent time with the children and threw them a pizza party and handed out ...
(Date:9/17/2019)... AUCKLAND, New Zealand (PRWEB) , ... September 17, 2019 , ... ... Mention in in Fast Company’s 2019 Innovation by Design Awards Students category. , It ... Lab at the Auckland Bioengineering Institute. , Muss-Bits is comprised of two parts. A ...
Breaking Medicine Technology:
(Date:9/17/2019)... BROOKFIELD, Wis. (PRWEB) , ... September 17, 2019 , ... Milwaukee-area dealership Hall Cars has ... have been affected by cancer. The event, entitled “Drive Out Cancer,” entails that for every ... This Time Tomorrow Foundation. As the event lasts for 50 days, it has also been ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... for Europe and the 21st Century Cures Act in the US, Nocimed has ... and pain management. Using images from existing MRI equipment to perform MR ...
(Date:9/17/2019)... ... September 17, 2019 , ... Drs. Charles Felts and ... teeth in Chattanooga, TN for customized full mouth dental implants with TeethXpress® ... one day, providing a permanent tooth replacement solution for patients who struggle with ...
(Date:9/17/2019)... ... ... Lubin Austermuehle, P.C. will be one of the sponsors of GRIN2B ... Found Kitchen and Social House in Evanston on Monday, October 7 from 6 p.m. ... rare condition that results from changes to the GRIN2B gene. The GRIN2B gene is ...
(Date:9/17/2019)... ... September 17, 2019 , ... Genomenon ... with the goal of providing resources to assist researchers and encourage pharmaceutical companies ... disease causing abnormal iron deposits in the brain. , BPAN Warriors is ...
Breaking Medicine News(10 mins):